Gynecological tumors revealing hereditary nonpolyposis colorectal cancer: Analysis of a large Lebanese pedigree

International Journal of Gynecological Cancer

Volumn 16, Issue 4, 2006, Pages 1516-1521

  Akoum, R ^a   Ghaoui, A ^b   Brihi, E ^a   Ghabash, M ^b   Abou Atme, J ^a  

^a RIZK HOSPITAL   (Lebanon)

^b Hôpital des S urs du Rosaire   (Lebanon)

Author keywords

Gynecological cancers; Lynch syndrome; Screening; Surveillance

Indexed keywords

ADENINE; GENE PRODUCT; GENOMIC DNA; GUANINE; PROTEIN MSH2;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN; CANCER FAMILY; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; COLORECTAL CANCER; COURSE EVALUATION; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SEQUENCE; EARLY CANCER; ENDOMETRIUM; ENDOMETRIUM CANCER; EVALUATION; FEMALE; FEMALE GENITAL TRACT TUMOR; FLUORESCENCE ANALYSIS; FOLLOW UP; GENE MUTATION; GENETIC RISK; GERM LINE; HETEROZYGOSITY; HUMAN; INTRON; LEBANON; MALE; MISMATCH REPAIR; ONSET AGE; OVARY; OVARY CANCER; PEDIGREE ANALYSIS; PENETRANCE; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SKIN; SMALL INTESTINE;

ADENOCARCINOMA, PAPILLARY; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; DNA REPAIR; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; LEBANON; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; OVARIAN NEOPLASMS; PEDIGREE; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 33745953022     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00621.x     Document Type: Article

References (31)

1. Peltomaki P. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 2001;10:735-40.
2. Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). Cancer 1996;78:1149-67.
3. Lynch HT, De la Chapelle. Hereditary colorectal cancer. N Engl J Med 2003;348:919-32.
4. Cunningham JM, Kim CY, Christensen ER et al. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 2001;69:780-90.
5. Di Fiore F, Charbonnier F, Martin C, Frerot S, Olschwang S, Wang Q. Screening for genomic rearrangement of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet 2004;41:18-20.
6. Charbonnier F, Olschwang S, Wang Q et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in HNPCC. Cancer Res 2002;62:848-53.
7. Liu SR, Zhao B, Wang ZJ, Wan YL, Huang X. Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma. World J Gastroenterol 2004;10:2647-51.
8. Cai SJ, Xu Y, Cai GX et al. Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer. World J Gastroenterol 2003;9:284-7.
9. Cai Q, Sun MH, Lu HF, Zhang TM, Mo ST, Xu y. Clinicopathological and molecular genetic analysis of 4 typical Chinese HNPCC families. World J Gastroenterol 2001;7:805-10.
10. Bertario L, Aste H, Arrigoni A et al. Clinical aspects and management of hereditary non-polyposis colorectal cancer (HNPCC). Tumori 1996;82:117-21.
11. Bradshaw N, Holloway S, Penman I, Dunlop MG, Porteous MEM. Colonoscopy surveillance of individuals at risk of familial colorectal cancer. Gut 2003;52:1748-51.
12. Chen-Shtoyerman R, Theodor L, Harmati E et al. Genetic analysis of familial colorectal cancer in Israeli-Arabs. Hum Mutat 2003;21:446-7.
13. Soliman AS, Bondy ML, El-Badawy SA et al. Contracting molecular pathology of colorectal carcinoma in Egyptian and Western patients. Br J Cancer 2001;85:1037-46.
14. Soliman AS, Bondy ML, Levin B et al. Familial aggregation of colorectal cancer in Egypt. Int J cancer 1998;77:811-6.
15. Mitchell RJ, Farrington SM, Dunlop MG, Campbell H. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am J Epidemiol 2002;156:885-902.
16. Gille JJP, Hogervorst FBL, Pals G et al. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002;87:892-7.
17. Rodriguez-Bigas MA, Lee PH, O'Malley L et al. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 1996;39:649-53.
18. Ramesar RS, Madden MV, Felix R, Harocopos CJ, Westbrook CA, Jone G. Molecular Genetics improves the management of hereditary non polyposis colorectal cancer. S Afr Med J 2000;90:709-21.
19. Watson P, Narod SA, Fodde R, Wagner A, Lynch JF, Tinley ST. Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer. J Med Genet 2003;40:591-6.
20. Konishi K, Tajiri H, Fujii T, Boken N, Ohtu A, Yoshida S. Hereditary nonpolyposis colorectal cancer associated with duodenal carcinoma: a case report. Jpn J Clin Oncol 1998;28:289-93.
21. Foulkes WD, Thiffault I, Gruber SB et al. The founder mutation MSH2*1906G→C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 2002;71:1395-412.
22. Vasen HFA, Stormorken A, Menko FH et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001;19:4074-80.
23. Wagner A, Hendricks Y, Meijers-Heijboer EJ et al. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet 2001;38:318-22.
24. Rossi BM, Lopez A, Ferreira FO, Nakagawa WT, Napoli-Ferreira CC, Casali de Rocha C. hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol 2002;9:555-61.
25. Ponz de Leon M, Benatti P, Borghi F et al. Aetiology of colorectal cancer and relevance of monogenic inheritance. Gut 2004;53:115-22.
26. Ponz de Leon M, Benatti P, Percesepe A et al. Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree. Ital J Gastroenterol Hepatol 1999;31:476-80.
27. Kurzawski G, Suchy J, Ktadny J et al. Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States. J Med Genet 2002;39:65.
28. Bai YQ, Akiyama Y, Nagazaki H et al. Predominant germ-line mutation of the MSH2 gene in Japanese hereditary non-polyposis colorectal cancer kindreds. Int J Cancer 1999;82:512-5.
29. Percesepe A, Borghi F, Menigatti M et al. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol 2001;19:3944-50.
30. Katballe N, Christensen M, Wikman FP, Orntoft TF, Laurberg S. Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut 2002;50:43-51.
31. Bougeard G, Charbonnier F, Moerman A et al. Early onset brain tumor and lymphoma in MSH2-deficient children. Am J Hum Genet 2003;72:213-6.